Fig. 6: HRAS-mutant cancer cell proliferation is decreased by TAT-L5UR peptides.
From: Identification of an H-Ras nanocluster disrupting peptide
a–d 2D cell viability of Hs 578 T (a), T24 (b), MIA PaCa-2 (c), and HEK (d) cells in response to 48 h treatment with TAT-L5URcore peptides and TAT-control; n = 3. e Drug sensitivity score (DSS3), an area under the curve metric, calculated for the viability data in (a–d). A higher value indicates a stronger anti-proliferative effect. TAT-control was used as a reference for statistical comparisons.
